These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5001974)

  • 1. Pseudomonas agglutinins in patients with cystic fibrosis.
    Habboushe C; Iacocca V; Braddock L; Barbero G
    Pediatrics; 1971 Dec; 48(6):973-4. PubMed ID: 5001974
    [No Abstract]   [Full Text] [Related]  

  • 2. Microbiological background for anti-Pseudomonas aeruginosa vaccination in cystic fibrosis.
    Bauernfeind A; Przyklenk B
    Behring Inst Mitt; 1997 Feb; (98):256-61. PubMed ID: 9382748
    [No Abstract]   [Full Text] [Related]  

  • 3. Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response.
    Hoiby N
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):551-8. PubMed ID: 4213330
    [No Abstract]   [Full Text] [Related]  

  • 4. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis.
    Vogelberg C; Hirsch T; Rösen-Wolff A; Kerkmann ML; Leupold W
    Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of Pseudomonas aeruginosa strains in seven cystic fibrosis patients followed over 20 months.
    Godard C; Plesiat P; Michel-Briand Y
    Eur J Med; 1993 Feb; 2(2):117-20. PubMed ID: 8258014
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of Pseudomonas aeruginosa in patients with cystic fibrosis.
    Tramper-Stranders GA; van der Ent CK; Wolfs TF
    J Cyst Fibros; 2005 Aug; 4 Suppl 2():37-43. PubMed ID: 15961356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serogroups of Pseudomonas aeruginosa and the immune response of patients with cystic fibrosis.
    Diaz E; Mosovich LL; Neter E
    J Infect Dis; 1970 Mar; 121(3):269-74. PubMed ID: 4984335
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis.
    Carlsson M; Eriksson L; Pressler T; Kornfält R; Mared L; Meyer P; Wiik A; Wieslander J; Segelmark M
    J Cyst Fibros; 2007 May; 6(3):228-33. PubMed ID: 17166780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel chromogenic medium for isolation of Pseudomonas aeruginosa from the sputa of cystic fibrosis patients.
    Laine L; Perry JD; Lee J; Oliver M; James AL; De La Foata C; Halimi D; Orenga S; Galloway A; Gould FK
    J Cyst Fibros; 2009 Mar; 8(2):143-9. PubMed ID: 19097827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Pier GB
    Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.
    Savoia D; Deplano C; Zucca M
    Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response to Pseudomonas aeruginosa in children with cystic fibrosis.
    Milagres LG; Castro TL; Garcia D; Cruz AC; Higa L; Folescu T; Marques EA
    Pediatr Pulmonol; 2009 Apr; 44(4):392-401. PubMed ID: 19283764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotyping of Pseudomonas aeruginosa from patients with cystic fibrosis of the pancreas.
    Hirao Y; Homma JY; Zierdt CH
    Jpn J Exp Med; 1977 Aug; 47(4):249-54. PubMed ID: 411970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-pseudomonas-specific precipitins as a marker of chronic infection in patients with cystic fibrosis].
    Castello D; Mari C; Visca A
    Minerva Pediatr; 1999 Mar; 51(3):47-51. PubMed ID: 10368566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriological studies of bronchial secretions in 19 cases of cystic fibrosis.
    Feigelson J; Pecau Y
    Bibl Paediatr; 1967; 86():214-26. PubMed ID: 4964164
    [No Abstract]   [Full Text] [Related]  

  • 16. Polyagglutinable Pseudomonas aeruginosa from cystic fibrosis patients. A survey.
    Ojeniyi B
    APMIS Suppl; 1994; 46():1-44. PubMed ID: 7811529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Children with cystic fibrosis produce an immune response against exoenzyme S, a type III cytotoxin of Pseudomonas aeruginosa.
    Banwart B; Splaingard ML; Farrell PM; Rock MJ; Havens PL; Moss J; Ehrmantraut ME; Frank DW; Barbieri JT
    J Infect Dis; 2002 Jan; 185(2):269-70. PubMed ID: 11807706
    [No Abstract]   [Full Text] [Related]  

  • 18. Polymerase chain reaction for the detection of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia in sputum of patients with cystic fibrosis.
    Karpati F; Jonasson J
    Mol Cell Probes; 1996 Dec; 10(6):397-403. PubMed ID: 9025076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Slime from a mucoid strain of Pseudomonas aeruginosa in mucoviscidosis and other respiratory diseases (author's transl)].
    Marty N; Lapchine L; Pradere J; Dutau G
    Ann Pediatr (Paris); 1981 Apr; 28(4):261-5. PubMed ID: 6784657
    [No Abstract]   [Full Text] [Related]  

  • 20. [Production of elastase, exotoxin A and alkaline protease during bronchopulmonary exacerbations in patients with mucoviscidosis chronically infected by Pseudomonas aeruginosa].
    Jaffar-Bandjee MC; Carrere J; Bally M; Chazalette JP; Galabert C
    Pathol Biol (Paris); 1994 May; 42(5):505-9. PubMed ID: 7824322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.